FdaApplication
NDA 215425
Identifiers
- fda_app_no: NDA215425
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | NDA |
| approval_date | 2025-03-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPINEPHRINE | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
1 product